Mallinckrodt to Acquire Therakos for $1.33 Billion by CHAD BRAY

By CHAD BRAY

The deal for Therakos, a maker of immunotherapy drugs, is expected to broaden Mallinckrodt’s offerings and to expand its business in hospitals.

Published: August 11, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1IEajxm

from WordPress http://ift.tt/1DC7Gjl
via Hadi Aboukhater